ANGO

ANGO

AngioDynamics Powers Ahead with 7% Revenue Growth and Strong Med Tech Segment Performance

AngioDynamics, a leading medical technology company, has reported a strong start to its fiscal year 2027, driven by growth in its Med Tech segment. The company's total revenue grew by approximately 7%, marking a significant milestone in its transformation journey. In a conference call held on October 8th,

ANGO

AngioDynamics Delivers Strong Fiscal Year 2026 Performance with 18% Med Tech Growth

AngioDynamics, a leading medical technology company, recently reported its Fiscal Year 2026 fourth quarter and full year earnings call, showcasing impressive growth and profitability. The company's strong performance in the med tech segment, which accounted for 47% of total revenue, demonstrates its successful strategy to transform into a